- Home
- KIM vs SNN Comparison
KIM vs SNN Comparison
Compare KIM & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KIM | SNN |
|---|---|---|
| Founded | 1958 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 14.0B |
| IPO Year | 1991 | 1999 |
Fundamental Metrics
Financial Performance| Metric | KIM | SNN |
|---|---|---|
| Price | $20.43 | $32.93 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 4 |
| Target Price | $24.17 | ★ $32.83 |
| AVG Volume (30 Days) | ★ 4.8M | 501.7K |
| Earning Date | 10-30-2025 | 03-02-2026 |
| Dividend Yield | ★ 5.09% | 2.25% |
| EPS Growth | 57.13 | ★ 59.91 |
| EPS | ★ 0.83 | 0.56 |
| Revenue | $2,123,057,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $5.64 | $7.78 |
| Revenue Next Year | $3.02 | $5.13 |
| P/E Ratio | ★ $24.59 | $28.35 |
| Revenue Growth | ★ 8.14 | 5.35 |
| 52 Week Low | $17.93 | $23.69 |
| 52 Week High | $24.62 | $38.79 |
Technical Indicators
Market Signals| Indicator | KIM | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 50.51 | 46.47 |
| Support Level | $20.05 | $32.06 |
| Resistance Level | $20.59 | $33.60 |
| Average True Range (ATR) | 0.30 | 0.43 |
| MACD | 0.06 | 0.06 |
| Stochastic Oscillator | 71.47 | 44.32 |
Price Performance
Historical ComparisonAbout KIM Kimco Realty Corporation (HC)
One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 567 shopping centers throughout major markets in the US, representing roughly 101 million square feet.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.